LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $308,348 | -5.6% | 5,146 | +13.6% | 0.04% | -36.2% |
Q2 2023 | $326,469 | +1.4% | 4,528 | +3.4% | 0.06% | -3.3% |
Q1 2023 | $321,972 | -6.8% | 4,377 | -15.4% | 0.06% | -27.7% |
Q4 2022 | $345,623 | +49.6% | 5,174 | +236.8% | 0.08% | -63.6% |
Q4 2018 | $231,000 | -17.8% | 1,536 | -9.6% | 0.23% | -3.4% |
Q1 2018 | $281,000 | – | 1,699 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |